Effect of sodium tanshinone II a sulfonate on cardiac myocyte hypertrophy and its underlying mechanism

Chinese Journal of Integrative Medicine

Volumn 14, Issue 3, 2008, Pages 197-201

  Feng, Jun ^a   Zheng, Zhi ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Angiotensin II; c fos; Cardiac myocyte hypertrophy; Sodium tanshinone II A sulfonate

Indexed keywords

ANGIOTENSIN II; CARDIOVASCULAR AGENT; CHINESE DRUG; LEUCINE; MESSENGER RNA; PROTEIN C FOS; SODIUM TANSHINONE II A SULFONATE; UNCLASSIFIED DRUG; VALSARTAN;

ANIMAL CELL; ANIMAL CELL CULTURE; ARTICLE; CELL ASSAY; CELL SIZE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOTOXICITY; DRUG EFFECT; DRUG MECHANISM; GENE EXPRESSION; HEART MUSCLE CELL; HEART PROTECTION; HEART VENTRICLE HYPERTROPHY; NEWBORN; NONHUMAN; PHASE CONTRAST MICROSCOPY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; PROTO ONCOGENE; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANGIOTENSIN II; ANIMALS; ANIMALS, NEWBORN; CELL SURVIVAL; GENE EXPRESSION REGULATION; HYPERTROPHY; LEUCINE; MYOCYTES, CARDIAC; PHENANTHRENES; PROTO-ONCOGENE PROTEINS C-FOS; RATS; RATS, WISTAR; RNA, MESSENGER; TIME FACTORS; TRITIUM;

EID: 54549121369     PISSN: 16720415     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11655-008-0197-y     Document Type: Article

References (13)

1. Messerli FH, Ketelhut R. Left ventricular hypertrophy: a pressure-independent cardiovascular risk factor. J Cardiovasc Pharmacol 1993; 22 (suppl 1):s7-s13.
2. 1 receptor subtype. Cre Res 1993;73:413-423.
3. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 1983;65:55-63.
4. Yang K, Mu XS, Xue JJ, et al. Increased expression of c-fos mRNA and AP-1 transcription factors after cortical impact injury in rat. Brain Res 1994;664:141-147.
5. Tang W, Eisenbrand G. Salvia militiorrhiza Bge. Chinese drugs of plant origin. Berlin: Spring-Verlag, Germany, 1992:891-902.
6. Shanghai Cooperative Group for the study of tanshinone II A. Therapeutic effect of tanshinone II A sulfonate in patients with coronary heart disease: a double blind study. J Tradit Chin Med 1984;4(1);20-24.
7. Hefti MA, Hander BA, Eppenberger HM, et al. Signaling of pathways in cardiac myocyte hypertrophy. J Mol Cell Cardiol 1997;29:2873-2892.
8. Sadoshima J, Izumo S. Signal transduction pathways of angiotensin II -induced c-fos gene expression in cardiac myocytes in vitro. Roles of phospholipid-derived second messengers. Circ Res 1993;73:424-438.
9. 2+ exchanger by phenylephrine, angiotensin II and endothelin 1. J Mol Cell Cardiol 1996;28:11-17.
10. Chien KR, Knowlton KU, Zhu H, et al. Regulation of cardiac gene expression during myocardial growth and hypertrophy: molecular studies of an adaptive physiologic response. FASEB J 1991;5:3037-3046.
11. Liu QY, Tsai TD. Effects of sodium tanshinone II-A sulfonate on slow action potentials of dissociated single ventricular cells of adult guinea pig heart. Acta Physiol Sin 1990;42(3):254-261.
12. Li F, Wang XM, Li XZ, et al. A time-related study about morphometry in myocardial ultrastructure and Ca distribution in ischemia and reperfusion damage and the protective effect of Danshen for the heart. Chin J Pathophysiol (Chin) 1992;8(6):565-568.
13. 2+ current of single ventricular myocyte from guinea pig. Chin J Pharmacol Toxical (Chin) 1996; 10(2):81-84.